News

Merck & Company, Inc. (NYSE:MRK) is one of the high-margin pharma stocks to buy now. Jefferies has raised its price target on ...
Merck KGaA said its Ezmekly therapy for people with a rare genetic disorder has received the conditional marketing approval ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Iovance Biotherapeutics, Inc. stock faces challenges with disappointing Q1 earnings and competition. Click for why potential ...
The state food sales tax is ending, saving families $500 annually. And Merck expands in De Soto, boosting jobs.
ZoomRx surveyed 57 neurologists in the U.S. this month, revealing that no single drug brand holds more than 5% of top-of-mind ...
Biotech deals involving assets developed in China are surging, a Jefferies report shows. | Biotech deals involving assets ...
Five months after taking over the federal agency responsible for the health of all Americans, Robert F. Kennedy Jr. wants to ...
Calley Means, who has criticized the recommended U.S. vaccine schedule for youths and has no medical training, is a special ...
HealthDay News — Pharmacologic treatment of hypercholesterolemia falls short of U.S. and European guidelines, according to a study published online June 30 in the Journal of General Internal Medicine.
From J&J to BMS, New Jersey pharmaceutical companies continue to expand and transform through M&A, leadership shifts and ...
Verona Pharma has seen its stock price jump by 125 percent year-to-date, closing at $104.74 versus $46.44 in the last trading ...